Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2013

May 30, 2013

33819_dirs_2013-05-29_cd1b452e-f236-4862-9d49-5f6ee303c380.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2013-05-24

Reporting Person: CRAIG STEWART (SVP, Development & Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-24 Common Stock A 280000 $0.00 Acquired 420658 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 13316 Indirect

Footnotes

F1: Restricted stock units, with 1/4 vesting on May 24, 2014, 1/4 vesting on May 24, 2015, 1/4 vesting on May 24, 2016, and 1/4 vesting on May 24, 2017.

F2: Includes (1) 280,000 restricted stock units, with 70,000 of this vesting on each of May 24, 2014, May 24, 2015, May 24, 2016, and May 24, 2017; (2) 97,500 restricted stock units, with 32,500 of this vesting on each of January 27, 2014, January 27, 2015, and January 27, 2016; (3) 10,000 restricted stock units, with 5,000 vesting on each of June 1, 2013 and June 1, 2014; and (4) 2,333 restricted stock units vesting on September 15, 2013.

F3: Shares held in 401(k) account, in accordance with issuer's employer-match policies.